Latest News

It's been a good week for G Mining Ventures Corp. ( TSE:GMIN ) shareholders, because the company has just released its...

Sernova Biotherapeutics Inc ( TSE:SVA ) is possibly approaching a major achievement in its business, so we would like...

Whilst it may not be a huge deal, we thought it was good to see that the Medalist Diversified REIT, Inc. ( NASDAQ:MDRR...

Dye & Durham (TSX:DND) just debuted its Tax Certificates Online platform for the City of Hamilton, bringing its digital solution to another Ontario municipality. This move streamlines property tax certificate access and supports a more efficient experience for professionals and residents alike. See our latest analysis for Dye & Durham. Even as Dye & Durham rolls out new digital platforms and expands its municipal footprint, the company’s share price return has been challenged, down 51.99%...

Voyager Therapeutics, Inc. ( NASDAQ:VYGR ) shares have retraced a considerable 26% in the last month, reversing a fair...

Investors who take an interest in Arq, Inc. ( NASDAQ:ARQ ) should definitely note that the CEO, President & Director...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Companhia Brasileira de Alumínio's ( BVMF:CBAV3 ) stock was strong after they recently reported robust earnings...

Key Insights Quantum-Si's significant retail investors ownership suggests that the key decisions are influenced by...

Wondering if Keyera is undervalued or fairly priced? You are not alone, as many investors are taking a closer look at this stock's potential. In the past week, Keyera shares gained 5.7%, even though the stock is nearly flat over the past year and down 2.5% year-to-date. This recent momentum is all the more eye-catching. This price action comes after analysts and market watchers highlighted Keyera’s strategic midstream asset investments and a major infrastructure partnership announced earlier...

Restaurant Brands International Limited Partnership (TSX:QSP.UN) stock has seen steady gains over the past month, catching the attention of investors looking for consistency. With these recent moves, it is a good moment to revisit the company’s ongoing performance and outlook. See our latest analysis for Restaurant Brands International Limited Partnership. The momentum in Restaurant Brands International Limited Partnership’s share price has picked up lately, reflecting renewed confidence as...

Key Insights The considerable ownership by private companies in Trisul indicates that they collectively have a greater...

Lianlian DigiTech (SEHK:2598) has been catching some attention lately, with shares moving in various directions over the past week and month. Investors are weighing recent trading patterns in relation to the company’s overall financial trajectory. See our latest analysis for Lianlian DigiTech. Lianlian DigiTech’s share price has swung lower over the past quarter, with a 90-day share price return of -17.96% and a one-year total shareholder return of -13.4%. While momentum has faded recently,...

Earlier this month, Cytek Biosciences reported third-quarter 2025 earnings, showing revenue of US$52.29 million and a net loss of US$5.48 million compared to net income in the prior year, and reaffirmed its full-year revenue guidance of US$196 million to US$205 million. This combination of improved quarterly revenue but a swing to quarterly and year-to-date losses provided investors with contrasting signals about Cytek’s ongoing financial health and outlook. We’ll review how the...

Autolus Therapeutics (AUTL) just released its latest quarterly earnings and is drawing increased investor attention thanks to several key developments. The company continues to expand commercial access for Obe-cel, reports strong manufacturing results, and anticipates new data at the upcoming ASH conference. See our latest analysis for Autolus Therapeutics. Autolus Therapeutics has seen a burst of activity lately, from broadening commercial access and updating its leadership team to advancing...

Anavex Life Sciences (AVXL) reported that its lead drug candidate, blarcamesine, for early Alzheimer's disease faced a negative trend vote from the European Medicines Agency's CHMP. This outcome has sparked new questions about regulatory pathways and next steps for the company. See our latest analysis for Anavex Life Sciences. Anavex’s regulatory news contributed to a dramatic shift in sentiment, with the stock’s 1-day share price return tumbling 35.94% and momentum clearly fading. Despite...

EssoF (ENXTPA:ES) just announced a hefty €60.21 per share special dividend, set for November 14, 2025, after shareholders gave the green light during the recent Combined General Meeting. Investors are paying close attention. See our latest analysis for EssoF. That extraordinary dividend comes after an eventful year for EssoF, with the share price recently closing at €47.44. Despite a sharp drop in price over the past month and year-to-date, investors who held on for the past twelve months...

Semperit Aktiengesellschaft Holding ( VIE:SEM ) last week reported its latest quarterly results, which makes it a good...

It's been a pretty great week for ALK-Abelló A/S ( CPH:ALK B ) shareholders, with its shares surging 15% to kr.230 in...

The market rallied behind SpectrumOne AB (publ)'s ( STO:SPEONE ) stock, leading do a rise in the share price after its...

Investors in Infineon Technologies AG ( ETR:IFX ) had a good week, as its shares rose 7.9% to close at €35.30 following...

The board of Fuller, Smith & Turner P.L.C. ( LON:FSTA ) has announced that it will pay a dividend of £0.0785 per share...

Last week's earnings announcement from EQL Pharma AB (publ) ( STO:EQL ) was disappointing to investors, with a sluggish...

Altron Limited ( JSE:AEL ) is about to trade ex-dividend in the next three days. Typically, the ex-dividend date is two...